Cited by 694Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and MetabolismPI3K/AKT/mTOR signaling in cancer

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Open access
Yuneva, Mariia, Zamboni, Nicola, Oefner, Peter, Sachidanandam, Ravi, Lazebnik, Yuri·2007·The Journal of Cell Biology

Abstract

The idea that conversion of glucose to ATP is an attractive target for cancer therapy has been supported in part by the observation that glucose deprivation induces apoptosis in rodent cells transduced with the proto-oncogene MYC, but not in the parental line. Here, we found that depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis. However, depletion of glutamine, another major nutrient consumed by cancer cells, induced apoptosis depending on MYC activity. This apoptosis was preceded by depletion of the Krebs cycle intermediates, was prevented by two Krebs cycle substrates, but was unrelated to ATP synthesis or several other reported consequences of glutamine starvation. Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy, and that understanding how glutamine metabolism is linked to cell viability might provide new approaches for treatment of cancer.

AI snapshot

Written from the paper’s full text.

TL;DR

In human cells, glucose deprivation killed normal fibroblasts independently of MYC and not by apoptosis, whereas glutamine deprivation induced MYC-dependent apoptosis. The glutamine-dependent death was linked to depletion of Krebs cycle intermediates and was prevented by pyruvate or oxaloacetate, but not by ATP, glutathione, DNA damage, protein synthesis, or mTOR mechanisms.

Key findings

  • Glucose depletion killed IER-MYC human fibroblasts irrespective of ERTM-MYC activity; 0.5 mM glucose (2% of normal) killed more slowly but also independently of MYC. Death was not apoptosis, as shown by absence of chromatin condensation and failure of Bcl-2 to prevent death.
  • Glutamine depletion killed IER-MYC cells faster when ERTM-MYC was active; IER control cells remained viable without glutamine regardless of OHT. Death was apoptosis via the intrinsic pathway: Bcl-2 and caspase-9 dominant-negative prevented death, while crmA had no effect.
  • Apoptosis after glutamine depletion was not caused by ATP deficiency, glutathione deficiency, DNA damage, protein synthesis deficiency, mTOR inhibition, or cell cycle arrest. Glutamine deprivation depleted Krebs cycle intermediates except citrate and isocitrate; pyruvate or oxaloacetate completely prevented apoptosis but did not restore proliferation, and the NADH/NAD ratio remained unchanged.
  • Nutrient requirements varied by cell type: HFF-ER-MYC reacted like IER-MYC; HA1E cells underwent apoptosis after glucose depletion and reacted to glutamine depletion like IER-MYC; RPE-hTERT cells survived without glutamine irrespective of ectopic MYC and died without glucose independently of MYC by a non-apoptotic mechanism.

Methods

  • Normal human fibroblasts IMR90 were retrovirally transduced with ERTM-MYC (IER-MYC) or ERTM alone (IER); HFF, HA1E, and RPE-hTERT cells were also tested. ERTM-MYC was activated with 200 nM 4-hydroxytamoxifen (OHT), with ethanol as vehicle.
  • Nutrient depletion used glucose-free or glutamine-free DMEM; standard concentrations were 10 mM glucose and 2 mM glutamine. Viability and apoptosis were assessed by annexin V/PI, Hoechst 33342 nuclear morphology, Trypan Blue, and immunoblotting/immunofluorescence.
  • Metabolite and viability analyses included ATP by luciferin-luciferase, reduced glutathione by flow cytometry, NADH/NAD by enzymatic cycling, lactate by LDH reaction, and capillary electrophoresis coupled to mass spectrometry (CE-MS) for metabolite profiling. Results are presented as averages of independent experiments with SDs where indicated.

Limitations

  • Stated: how abnormal MYC synergizes with glutamine depletion to induce apoptosis remains to be determined; the authors cannot exclude a combination of tested mechanisms or an unknown glutamine function. Mitochondrial NADH/NAD+ and FADH/FAD+ ratios were not measured.
  • Stated: the effect of nutrient depletion varied across cell types, so conclusions may be difficult to extrapolate from one or a few experimental systems.
  • Evident: the study relies on ectopically expressed inducible ERTM-MYC in cultured human cell lines rather than endogenous MYC or in vivo tumor models; several supporting observations are described as unpublished or are based on two independent experiments.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1083/jcb.200703099

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 18 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    In normal human fibroblasts (IER-MYC), glucose deprivation kills cells irrespective of ERTM-MYC activity.

    “depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis.”
    • Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · plain
      “depletion of glucose killed IER-MYC cells irrespective of ERTM-MYC activity (Fig. 1, A and B).”
    Quote in the paperSubstantial claim
  • Findingown data

    Glucose deprivation kills IER-MYC cells by a process other than apoptosis.

    “by a mechanism different from apoptosis.”
    • Also stated in: § Glucose deprivation kills normal human fibroblasts not by apoptosis and largely independently of the MYC activity · hedged
      “cells in our system died by a process other than apoptosis, as indicated by the absence of characteristic chromatin condensation (Fig. 1 C) and the failure of Bcl-2, an inhibitor of apoptosis, to prevent cell death (Fig. 1 D).”
    Quote in the paperSubstantial claim
  • Findingown data

    Glutamine depletion prevented the increase in p53 concentration caused by activation of ERTM-MYC.

    “glutamine depletion even prevented the increase in p53 concentration caused by activation of ERTM-MYC”
    Quote in the paperSubstantial claim
  • Findingown data

    Glutamine deprivation-induced apoptosis in IER-MYC cells proceeds through the intrinsic pathway.

    “Apoptosis was induced through the intrinsic pathway because Bcl-2 and a caspase-9 dominant-negative mutant (C9DN) prevented death (Fig. 3, A and B), whereas crmA, a viral inhibitor of the extrinsic pathway (Enari et al., 1995), had no effect (Fig. 3 D).”
    Quote in the paperSubstantial claim
  • Findingown data

    The antioxidants tiron and N-acetyl-cysteine failed to rescue glutamine-depleted cells from apoptosis.

    “the antioxidants that we tested, tiron and N-acetyl-cysteine, failed to rescue the depleted cells from apoptosis (unpublished data)”
    Quote in the paperSubstantial claim
  • May combine two claims. 11
  • Classified as probably not a substantial claim. 15
  • May combine two claims.

    Findingown data

    Glutamine depletion does not induce DNA damage; it does not increase p53 and does not induce H2AX phosphorylation.

    “glutamine depletion not only failed to increase the p53 concentration, but even reversed the increase induced by activation of ERTM-MYC (Fig. 7).”
    • Also stated in: § Glutamine depletion does not cause DNA damage · plain
      “Phosphorylation of H2AX, as detected by immunofluorescence, was induced by etoposide and by activation of ERTM-MYC, but not by glutamine depletion (Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1).”
    • Also stated in: § Glutamine depletion does not cause DNA damage · hedged
      “Hence, depletion of glutamine was unlikely to cause apoptosis by inducing DNA damage.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Glutamine depletion does not change the NADH/NAD ratio and lactate is still produced.

    “the NADH/NAD ratio remained unchanged (Fig. 8 D) and lactate was still produced (Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1) after glutamine depletion, even though at a lower rate, indicating that pyruvate was unlikely to rescue from glutamine depletion by being a substrate of LDH.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    mTOR inhibition is not the cause of apoptosis induced by glutamine depletion; the apoptosis does not require mTOR activity.

    “rapamycin caused S6 dephosphorylation but had no effect on cell viability over the time sufficient to kill cells by glutamine depletion (Fig. 4 C). Hence, glutamine depletion caused apoptosis by affecting pathways that did not require mTOR activity.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Depletion of essential amino acids caused cell cycle arrest but not apoptosis.

    “in our hands depletion of essential amino acids caused cell cycle arrest but not apoptosis”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Lactate production remains largely unchanged after depletion of glutamine and is independent of ER-MYC activity.

    “Fig. S3 documents that lactate production remains largely unchanged after depletion of glutamine and is independent of ER-MYC activity”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Glutamine depletion caused cell cycle arrest irrespective of ERTM-MYC activity.

    “glutamine depletion caused cell cycle arrest irrespective of the ERTM-MYC activity (unpublished data)”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductcitation

    C9DN expression prevents cell disassembly but not preceding steps of apoptosis, avoiding artifacts.

    “we used IER-MYC that expressed C9DN (IER-MYC–C9DN), which prevents cell disassembly but not the preceding steps of apoptosis (Fearnhead et al., 1998), thus avoiding artifacts associated with cell decomposition.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Fearnhead et al., 1998

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    Identification of metabolites was based on retention time and exact mass measurements after alignment of both axes with reference compounds, and confirmed by spiked standards.

    “Identification was based on retention time and exact mass measurements after alignment of both axes with reference compounds, and confirmed by spiked standards.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Metabolism of human cells is changed by oncogenes in various ways.

    “metabolism of human cells is changed by oncogenes in various ways (Ramanathan et al., 2005)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ramanathan et al., 2005

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S1 (asserted).

    Premisecitation

    Glutamine depletion kills because of stress caused by deficiency in proteins, ATP, glutathione, or nucleotides.

    “previous reports suggested that depletion of glutamine kills because of stress caused by deficiency in proteins, ATP, glutathione, or nucleotides (for review see Ahluwalia et al., 1990; Fuchs and Bode, 2006).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Ahluwalia et al., 1990

      Not checked in the free run.

    • cites Fuchs and Bode, 2006

      Not checked in the free run.

  • May combine two claims.

    Study design and conductown data

    The ERTM-MYC system functioned as expected, as shown by OHT-induced nuclear translocation and increased DNA damage sensitivity.

    “Adding OHT to the tissue culture medium caused translocation of ERTM-MYC to the nucleus (Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200703099/DC1) and increased sensitivity of the cells to DNA damage (Fig. S1 B), which confirmed that the system functioned as expected (Eilers et al., 1989; Littlewood et al., 1995).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Eilers et al., 1989

      Not checked in the free run.

    • cites Littlewood et al., 1995

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Pyruvate can affect cell viability by being a substrate of LDH, which oxidizes NADH to NAD.

    “Pyruvate might affect cell viability by being a substrate of lactate dehydrogenase (LDH), which oxidizes NADH to NAD (Zielke et al., 1980).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zielke et al., 1980

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Treatments that induce glutamine deficiency or interfere with its metabolism as a substrate for nucleotide synthesis were highly successful in animals, but turned out to be unacceptably toxic in people and were largely abandoned.

    “Treatments that induce glutamine deficiency or interfere with its metabolism as a substrate for nucleotide synthesis were highly successful in animals, but turned out to be unacceptably toxic in people and were largely abandoned (Ahluwalia et al., 1990).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Ahluwalia et al., 1990

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning

    Our study is consistent with the view that metabolic changes associated with carcinogenesis, and energy metabolism in particular, might be much more complex than Warburg postulated.

    “Overall, our study is consistent with the view that metabolic changes associated with carcinogenesis, and the energy metabolism in particular, might be much more complex than Warburg postulated”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    In this system, glutamine is either the main source of Krebs cycle intermediates or regulates Krebs cycle activity.

    “our observations indicated that glutamine in our system is either the main source of Krebs cycle intermediates, as in some proliferating normal and cancer cells (Reitzer et al., 1979; Moreadith and Lehninger, 1984; Zielke et al., 1984; Kovacevic et al., 1991; Baggetto, 1992; Petch and Butler, 1994), or regulates the Krebs cycle activity.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The potential of glutamine metabolism as a target for cancer therapy may need revisiting.

    “suggests that the potential of glutamine metabolism as a target for cancer therapy may need revisiting”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The NADH/NAD ratio determines rates of many processes, from glycolysis to histone modifications.

    “the NADH/NAD ratio determines rates of many processes, from glycolysis to histone modifications (for review see Ladurner, 2006)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ladurner, 2006

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation

    CE-MS estimates concentration of multiple metabolites in one sample.

    “capillary electrophoresis coupled to mass spectrometry (CE-MS), an approach that estimates concentration of multiple metabolites in one sample (Soga et al., 2003).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Soga et al., 2003

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All changes in brightness or contrast, if any done, were applied to the entire image.

    “All changes in brightness or contrast, if any done, were applied to the entire image.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    Retroviral transduction was used to decrease chances of clonal selection.

    “To further decrease the chances of clonal selection, we used retroviral transduction rather than transient transfection to generate populations of normal human fibroblasts IMR90 that expressed ERTM-MYC (IER-MYC) or ERTM (IER); the latter served to exclude effects of OHT unrelated to MYC activity.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Dependence of cells on glucose and the effects of its depletion vary among cell types and can depend on the combination of oncogenes expressed.

    “our results demonstrated that dependence of cells on glucose and the effects of its depletion vary among cell types and can depend on the combination of oncogenes expressed in these cells.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    The Krebs cycle is a hub of numerous metabolic pathways.

    “the Krebs cycle is not only a source of NADH for oxidative phosphorylation, but also a “hub” of numerous metabolic pathways (http://www.tcd.ie/Biochemistry/IUBMB-Nicholson/minimaps.html)”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationown data

    The fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy.

    “Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Depletion of glucose induces apoptosis in rodent cells transduced with MYC but not in the parental cell line.

    “depletion of glucose induced apoptosis in rodent cells that were transduced with MYC, an oncogene that is abnormally expressed in many human cancers (Nesbit et al., 1999), but not in the parental cell line (Shim et al., 1998).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Shim et al., 1998

      Not checked in the free run.

    • cites Nesbit et al., 1999

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Study design and conductown data

    ER-MYC is activated as expected.

    “Fig. S1, A and B document that ER-MYC is activated as expected”
    Quote in the paperSubstantial claim
25 of 25
  • The paper relies on this without support.

    Metabolism can vary among species.

    “Considering that metabolism can vary among species, and that human rather than animal tumors are of primary interest, we used human cells.”
  • The paper relies on this without support.

    Glutamine is made by cells, making the requirement for exogenous glutamine appear unnecessary.

    “However, glutamine is made by cells, which makes the requirement for exogenous glutamine appear unnecessary.”
  • The paper relies on this without support.

    Oxaloacetate is a membrane-permeable Krebs cycle intermediate and pyruvate can enter the Krebs cycle by converting into acetyl-CoA or oxaloacetate.

    “oxaloacetate, which is a membrane-permeable Krebs cycle intermediate, or pyruvate, which can enter the cycle by converting into acetyl-CoA or oxaloacetate, completely prevented apoptosis in the absence of glutamine (Fig. 8, A and B).”
  • The paper relies on this without support.

    Why glutamine is required for cell viability is not entirely clear.

    “Surprisingly, why glutamine is required for cell viability, or, in other words, why depletion of glutamine would kill cells, is not entirely clear.”
  • The paper relies on this without support.

    p53 is mutated in many cancers.

    “which is an advantage as this protein is mutated in many cancers”
5 of 5

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Depending on tissue of origin, cancer cells use various routes of glutamine metabolism; some require exogenous glutamine for malignant proliferation, whereas others do not and can synthesize it de novo.

    “Furthermore, depending on the tissue of origin, cancer cells use various routes of glutamine metabolism. Some have been shown to require an exogenous glutamine supply for malignant proliferation [71,72], whereas others do not [73] and can synthesize it de novo [74].”

    From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [71]

    The Introduction states that some cancer cell lines require glutamine or its metabolites for survival, supporting a glutamine dependency. It does not establish that they require an exogenous glutamine supply specifically for malignant proliferation; the paper chiefly examines cell survival and apoptosis after glutamine depletion. The sentence’s claims about other cells synthesizing glutamine de novo have separate citations and are not judged here. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Cancer cells often consume glutamine, and those dependent on Myc signaling are highly sensitive to glutamine withdrawal.

    “Cancer cells often consume glutamine, and those dependent on Myc signaling are highly sensitive to glutamine withdrawal (Yuneva et al., 2007).”

    From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Yuneva et al., 2007

    The Introduction identifies glutamine as a major nutrient consumed by cancer cells. The Results report that glutamine deprivation induced MYC-dependent apoptosis in tested human cells, but also describe a cell type that survived despite ectopic MYC expression. The Discussion presents sensitivity of cancers with abnormally high MYC activity as a possibility to explore, rather than an established general finding. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • CHK1 inhibitors and glutaminase inhibitors are considered potential candidates for treating Myc-overexpressing cancers.

    “Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
  • Providing alpha-ketoglutarate, oxaloacetate, or pyruvate rescues cancer cell proliferation under glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates (anaplerosis).

    “Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yuneva et al., 2007).”

    From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2007

  • In certain contexts, MYC-transformed cancers become glutamine dependent and undergo apoptosis in the absence of glutamine.

    “In certain contexts, MYC-transformed cancers become glutamine dependent and undergo apoptosis in the absence of glutamine (Yuneva et al., 2007).”

    From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yuneva et al., 2007

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • MYC-associated DNA damage is both reported and denied

    Major

    The Discussion says no increase in DNA damage was detected after ERTM-MYC activation, but the Results say ERTM-MYC activation induced phosphorylation of H2AX, which the paper uses as a DNA-damage reporter.

  • CrmA result cites a nonexistent Figure 3 panel

    Minor

    The text cites Figure 3 D for the CrmA result, but the Figure 3 caption identifies the CrmA experiment as panel C and lists no panel D.

  • Figure 6 C refers to a schematic as its treatment protocol

    Minor

    The caption says the cells in panel C were treated as in panel A, but panel A is a biosynthesis diagram. The treatment conditions are described in panel B.

3 of 3

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. 1969, Cancer Res., 29, 669
  2. 1969, Cancer Res., 29, 1195
  3. 1985, Eur. J. Cell Biol., 36, 176
  4. 2004, Anticancer Res., 24, 1121
  5. 2003, Cancer Res., 63, 7330
  6. 1984, Fed. Proc., 43, 121

Cited by

Sorted by citations

Authors
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., & Lazebnik, Y.
Affiliations
  • University of California, San Francisco (US)
  • ETH Zurich (CH)
  • University of Regensburg (DE)
  • Cold Spring Harbor Laboratory (US)
Corresponding author
Lazebnik, Yuri
Venue
The Journal of Cell Biology
Published
2007-07-02
Volume
178
Issue
1
Pages
93-105
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2112861594
Cited by
690
References
72
Citations by year
2026: 16 · 2025: 27 · 2024: 26 · 2023: 46 · 2022: 36 · 2021: 36 · 2020: 32 · 2019: 40 · 2018: 39 · 2017: 56 · 2016: 49 · 2015: 47 · 2014: 50 · 2013: 46 · 2012: 42
FWCI
7.28
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
Funders
National Cancer Institute (CA-13106-31, P01CA013106)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
glutamine deprivation, glucose deprivation, c-Myc, apoptosis, Krebs cycle intermediates, nutrient deprivation, cancer therapy, glutamine metabolism, cell viability, glucose metabolism
MeSH terms
Proto-Oncogene Mas, Cell Line, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Glucose, Glutamine, Humans, Lung, Male, Retroviridae, Skin, Transduction, Genetic, Proto-Oncogene Proteins c-myc, Apoptosis, Cell Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review